Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice

Maurizio Averna, Katherine Gorcyca, David Ansell, Şerban R. Iorga, Radovan Tomic, Georges Paizis, Francesca Fanelli, Aldo P. Maggioni, Alberico L. Catapano, Marcello Arca

Risultato della ricerca: Article

6 Citazioni (Scopus)

Abstract

Background and aims: Statin utilization and lipid goal achievement were estimated in a large sample of Italian patients at high/very-high cardiovascular (CV) risk. Methods: Patients aged â¥18 years with a valid low-density lipoprotein cholesterol (LDL-C) measurement in 2015 were selected from the IMS Health Real World Data database; non-high-density lipoprotein cholesterol (non-HDL-C) was assessed in those with available total cholesterol measurements. Index dates were defined as the last valid lipid measurement in 2015. Patients were hierarchically classified into mutually exclusive risk categories: heterozygous familial hypercholesterolemia (primary and secondary prevention), atherosclerotic CV disease (including recent acute coronary syndrome [ACS], chronic coronary heart disease, stroke, and peripheral arterial disease), and diabetes mellitus (DM) alone. Statin and non-statin lipid-modifying therapy (LMT) use, and European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) guideline-recommended goal attainment, were assessed. Results: Among 66,158 patients meeting selection criteria, the overall rate of LMT prescriptions was 53.3%, including 7.7% on high-intensity statin therapy. Statin use was highest for recent ACS and lowest for DM alone. LDL-C goal attainment was 16.0% for <1.8 mmol/l and 45.0% for <2.5 mmol/l; 24.3% reached non-HDL-C <2.6 mmol/l and 52.2% were at <3.3 mmol/l. Goal achievement was greatest with high-intensity statin use. Conclusions: Statin use in this cohort was consistent with previous reports in Italian patients at high/very-high CV risk, and low relative to statin use in other European countries. The low rate of ESC/EAS lipid goal attainment observed was consistent with outcomes of other European studies.
Lingua originaleEnglish
pagine (da-a)120-127
Numero di pagine8
RivistaATHEROSCLEROSIS
Volume271
Stato di pubblicazionePublished - 2018

    Fingerprint

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine

Cita questo

Averna, M., Gorcyca, K., Ansell, D., Iorga, Ş. R., Tomic, R., Paizis, G., Fanelli, F., Maggioni, A. P., Catapano, A. L., & Arca, M. (2018). Statin utilization and lipid goal attainment in high or very-high cardiovascular risk patients: Insights from Italian general practice. ATHEROSCLEROSIS, 271, 120-127.